These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6752018)

  • 1. Evidence for an unconventional virus in mouse-adapted Creutzfeldt-Jakob disease.
    Kingsbury DT; Smeltzer DA; Amyx HL; Gibbs CJ; Gajdusek DC
    Infect Immun; 1982 Sep; 37(3):1050-3. PubMed ID: 6752018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.
    Brown P; Wolff A; Gajdusek DC
    Neurology; 1990 Jun; 40(6):887-90. PubMed ID: 1693181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel replicating agent isolated from the human intestinal tract having characteristics shared with Creutzfeldt-Jakob and related agents.
    Burdon DW
    J Med Microbiol; 1989 Jun; 29(2):145-57. PubMed ID: 2659797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
    Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S
    Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent.
    Manuelidis EE; Fritch WW; Kim JH; Manuelidis L
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):871-5. PubMed ID: 3543937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease.
    Walker AS; Inderlied CB; Kingsbury DT
    Am J Public Health; 1983 Jun; 73(6):661-5. PubMed ID: 6342430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain.
    Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J
    Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenolized formalin may not inactivate Creutzfeldt-Jakob disease infectivity.
    Taylor DM
    Neuropathol Appl Neurobiol; 1989; 15(6):585-6. PubMed ID: 2693993
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains.
    Muramoto T; Kitamoto T; Tateishi J; Goto I
    Brain Res; 1992 Dec; 599(2):309-16. PubMed ID: 1291035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue.
    Brown P; Rohwer RG; Gajdusek DC
    J Infect Dis; 1986 Jun; 153(6):1145-8. PubMed ID: 3084671
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.
    Bockman JM; Kingsbury DT
    J Virol; 1988 Sep; 62(9):3120-7. PubMed ID: 2900341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Survival of Creutzfeldt-Jakob-disease virus in formol-fixed brain tissue.
    Gajdusek DC; Gibbs CJ
    N Engl J Med; 1976 Mar; 294(10):553. PubMed ID: 814460
    [No Abstract]   [Full Text] [Related]  

  • 13. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.
    Kimberlin RH; Walker CA; Millson GC; Taylor DM; Robertson PA; Tomlinson AH; Dickinson AG
    J Neurol Sci; 1983 Jun; 59(3):355-69. PubMed ID: 6308174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
    Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
    Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.
    Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral amyloid in mice with Creutzfeldt-Jakob disease is influenced by the strain of the infectious agent.
    Kitamoto T; Yi R; Mohri S; Tateishi J
    Brain Res; 1990 Jan; 508(1):165-7. PubMed ID: 2186845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transformation elicited by Creutzfeldt-Jakob-infected brain material.
    Oleszak EL; Manuelidis L; Manuelidis EE
    J Neuropathol Exp Neurol; 1986 Sep; 45(5):489-502. PubMed ID: 3528396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

  • 19. Routine use of phenolized formalin in fixation of autopsy brain tissue to reduce risk of inadvertent transmission of Creutzfeldt-Jakob disease.
    Brumback RA
    N Engl J Med; 1988 Sep; 319(10):654. PubMed ID: 3045549
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice.
    Chino F; Ohkawa T
    Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.